CCL22 and Alzheimer disease: Accordingly, we prepared a plasmid encoding an immunodominant self-B cell epitope of Aβ42, a foreign promiscuous T cell epitope, PADRE along with a molecular adjuvant, macrophage-derived chemokine (MDC/CCL22), and tested the efficacy of this vaccine in a 3xTg-AD mouse model.